US Weapons Stockpiles Face Shortages
Pharmaceutical importers in Italy are facing significant delays, with some medicines taking up to 18 months to reach the market following AIFA authorization. While European regulations suggest a 45-day window for parallel imports, current administrative hurdles make planning nearly impossible for businesses. This delay impacts the availability and pricing of essential medicines across the country. Italy has 9,700 inmates identified as drug addicts or dependents. Only a small portion of these individuals can obtain alternative detention measures in therapeutic communities. The shortage is attributed to a lack of adequate organization among prison services to facilitate transfers to rehabilitation programs. This situation is described as a result of the abandonment of social policies by both right-wing and left-wing governments.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“According to European regulations, parallel imports should take 45 days, but an importer today receives authorization after about 12 months, meaning entering the market after a year and a half.”
“9.700 detenuti tossico e dipendenti in Italia, solo una piccola parte di loro riesce a ottenere una misura alternativa alla detenzione presso una comunità terabiotica”
“We've done some analysis looking at seven key weapons that are used here, but also we used in the Western Pacific against China... the weapons are in short supply.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade